Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $60.57 ($462K) on 2014-04-15, disclosed to the SEC on 2014-04-17.
Scheduled sale ($462k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.57 | 2,100 | $127K | 27.5% |
| 2 | $61.53 | 2,900 | $178K | 38.6% |
| 3 | $62.38 | 1,800 | $112K | 24.3% |
| 4 | $63.27 | 700 | $44K | 9.6% |
| Total | $61.63 avg | 7,500 | $462K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |